Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GU Cancers 2021

2021 Genitourinary Cancers Symposium
11-13, February

The 2021 Genitourinary Cancers (GU) Symposium, held virtually, presented practice-changing data in the GU field and novel insights into burning questions, from Feb 11–13.

Leading experts from across the globe presented cutting-edge data, with a focus on translating this new evidence into multidisciplinary care. Explore the news here!

Prostate Cancer

View all
1:47
Soy isoflavones and oncology
Omer Kucuk • 9 Feb 2021
1:20
5-ARIs: impacts on prostate volume and PSA
James Kearns • 10 Feb 2021

Bladder Cancer

View all
2:13
INSPIRE: bladder-sparing chemoRT with durvalumab in LN+ urothelial cancer
Monika Joshi • 10 Feb 2021
3:53
KEYNOTE-992: pembrolizumab plus chemoRT for MIBC
Andrew Weickhardt • 11 Feb 2021

Trial Updates

View all
2:37
TheraP: cabazitaxel versus 177Lu-PSMA-617 for mCRPC
Declan Murphy • 9 Feb 2021
5:42
SPORT: P-SABR versus PPN-SABR for localized prostate cancer
Suneil Jain • 10 Feb 2021

Immuno-Oncology

View all
2:42
Sitravatinib, nivolumab and ipilimumab for accRCC
Pavlos Msaouel • 4 Feb 2021
1:41
Immunotherapy in the evolving MIBC treatment landscape
Andrew Weickhardt • 11 Feb 2021
The content of VJOncology is intended for healthcare professionals